News Focus
News Focus
Post# of 257577
Next 10
Followers 843
Posts 122987
Boards Moderated 9
Alias Born 09/05/2002

Re: genisi post# 143893

Wednesday, 10/10/2012 1:02:19 PM

Wednesday, October 10, 2012 1:02:19 PM

Post# of 257577
TEVA’s new data on thrice-weekly Copaxone are no big deal insofar as the comparator is placebo:

http://finance.yahoo.com/news/teva-present-positive-data-glatiramer-060000096.html

Teva will never run a head-to-head trial of thrice-weekly vs regular Copaxone.

See #msg-77016146, #msg-63817727, and #msg-76644423 for background.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today